Demographic data of the Greek haemophilia A and B population for the p
eriod 1972-1993 were analyzed. prevalence at birth including known not
-registered patients was calculated at 23.1 per 100,000 male births, H
owever, the observed prevalence in 1993 was only 61% of the expected.
Since 1975 the proportion of mild cases had significantly increased. A
djusted by age, severity and HIV status reproductive fitness of haemop
hiliacs was 0.62. Overall mortality was 2.6 times higher than in the g
eneral population, but 7.9 times among patients with severe haemophili
a and 16.4 among HIV(+) haemophiliacs. Fifty out of 78 deaths occurred
among HN(+) patients and 28 of these were caused by AIDS. Inhibitor p
atients did not show excess mortality due to bleeding. Cancer mortalit
y was equal to normal, but the number of deaths from ischaemic heart d
isease was 0.25 of the expected. Risk of death due to cerebral haemorr
hage was 3.8 times higher in HN(+) haemophiliacs than in HIV(-).